Buprenorphine Other names: Buprenorphine hydrochloride

Chemical formula: C₂₉H₄₁NO₄  Molecular mass: 467.64 g/mol  PubChem compound: 644073

Active ingredient description

Buprenorphine is an opioid partial agonist/antagonist which attaches itself to the μ (mu) and κ (kappa) receptors of the brain. Its activity in opioid maintenance treatment is attributed to its slowly reversible link with the μ receptors which, over a prolonged period, minimises the need of illicit opioids for patients with opioid dependence.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
N02AE01 Buprenorphine N Nervous system → N02 Analgesics → N02A Opioids → N02AE Oripavine derivatives
Discover more medicines within N02AE01
N07BC01 Buprenorphine N Nervous system → N07 Other nervous system drugs → N07B Drugs used in addictive disorders → N07BC Drugs used in opioid dependence
Discover more medicines within N07BC01

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
BUTRANS Transdermal system FDA, National Drug Code (US) MPI, US: SPL/PLR
SUBLOCADE Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
BUVIDAL Prolonged-release solution for injection European Medicines Agency (EU) MPI, EU: SmPC
BUPRENORPHINE Sublingual tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
RELETRANS Transdermal patch Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SIXMO Implant European Medicines Agency (EU) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 52485-79-7
CAS Substance: 53152-21-9
DrugBank Drug: DB00921
KEGG Drug: D07132
PubChem Compound: 644073
RxNorm Ingredient: 1819
SNOMED-CT Concept: 387173000
Buprenorphine (substance)
UNII Identifier: 40D3SCR4GZ
BUPRENORPHINE

Medicines

Buprenorphine is an active ingredient of these brands:

United States (US)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

  • (combination) SUBOXONE as BUPRENORPHINE HYDROCHLORIDE

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

  • OROBUPRE as BUPRENORPHINE HYDROCHLORIDE
  • SIXMO as BUPRENORPHINE HYDROCHLORIDE
  • SUBUTEX as BUPRENORPHINE HYDROCHLORIDE
  • TEMGESIC as BUPRENORPHINE HYDROCHLORIDE

  • (combination) SUBOXONE as BUPRENORPHINE HYDROCHLORIDE

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Italy (IT)

  • (combination) SUBOXONE as BUPRENORPHINE HYDROCHLORIDE

Japan (JP)

Lithuania (LT)

Malta (MT)

  • NATZON as BUPRENORPHINE HYDROCHLORIDE
  • SUBUTEX as BUPRENORPHINE HYDROCHLORIDE

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Romania (RO)

  • SIXMO as BUPRENORPHINE HYDROCHLORIDE

  • (combination) SUBOXONE as BUPRENORPHINE HYDROCHLORIDE
  • (combination) ZUBSOLV as BUPRENORPHINE HYDROCHLORIDE

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

  • NOPAN as BUPRENORPHINE HYDROCHLORIDE
  • TEMGESIC as BUPRENORPHINE HYDROCHLORIDE

  • (combination) SUBOXONE as BUPRENORPHINE HYDROCHLORIDE

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.